Published in Nephron on January 01, 1995
Folic acid supplementation rarely improves erythropoietin response. Nephron (1998) 0.96
Use of agents stimulating erythropoiesis in digestive diseases. World J Gastroenterol (2009) 0.79
Erythropoietin response to folic acid substitution. Nephron (1999) 0.75
Red cell folate: an appropriate index of folate body stores. Nephron (1997) 0.75
Assessing coronary stenosis. Quantitative coronary angiography versus visual estimation from cine-film or pharmacological stress perfusion images. Eur Heart J (1996) 2.18
Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. Crit Care Med (1996) 1.87
Energy metabolism in acute and chronic renal failure. Am J Clin Nutr (1990) 1.60
Decreased sensitivity of human platelets to PGI2 during long-term intraarterial prostacyclin infusion in patients with peripheral vascular disease--a rebound phenomenon? Prostaglandins (1981) 1.31
Automated data acquisition by confocal laser scanning microscopy and image analysis of triple stained immunofluorescent leukocytes in tissue. J Immunol Methods (2000) 1.10
Decreased vascular prostacyclin in juvenile-onset diabetes. N Engl J Med (1979) 1.06
Prostacyclin generation in atherosclerotic arteries. Lancet (1979) 1.04
Outcome prediction for patients with cirrhosis of the liver in a medical ICU: a comparison of the APACHE scores and liver-specific scoringsystems. Intensive Care Med (1996) 1.02
Recombinant human erythropoietin and hematopoietic progenitor cells in vivo. Blood (1989) 0.99
Spontaneous remission of acute myeloid leukemia after infection and blood transfusion associated with hypergammaglobulinaemia. Ann Hematol (1996) 0.98
Platelet sensitivity to prostacyclin in smokers and non-smokers. Chest (1986) 0.98
High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. J Trauma (1998) 0.97
Renin-angiotensin-aldosterone system in cyclosporin A-treated renal allograft recipients. Nephron (1985) 0.95
Quantitative investigation of sudanophilic lesions around the aortic ostia of human fetuses, newborn and children. Blood Vessels (1980) 0.95
Renin-angiotensin-aldosterone system and vasopressin in cyclosporine-treated renal allograft recipients. Clin Nephrol (1987) 0.95
Beneficial effect of renal transplantation on cognitive brain function. Kidney Int (1996) 0.93
Improvement of brain function in hemodialysis patients treated with erythropoietin. Kidney Int (1990) 0.92
Diminished prostacyclin formation in umbilical arteries of babies born to women who smoke. Lancet (1981) 0.92
Transient hyperoxaluria after ingestion of chocolate as a high risk factor for calcium oxalate calculi. Nephron (1989) 0.91
Implanted vascular prostheses generate prostacyclin. Lancet (1978) 0.87
Increased serum activity of interleukin-2 in patients with pre-eclampsia. J Autoimmun (1989) 0.85
Increased plasma histamine levels in chronic renal failure. N Engl J Med (1987) 0.84
Factors influencing the identification rate of the sentinel node in breast cancer. Eur J Cancer Care (Engl) (2011) 0.84
Prostacyclin (PGI2)-generation by different types of human atherosclerotic lesions. Exp Pathol (Jena) (1980) 0.83
Increased serum concentrations of adhesion molecules after coronary angioplasty. Clin Sci (Lond) (1994) 0.82
Treatment of lymphoceles following renal transplantation. Transplant Proc (1990) 0.81
Decreased prostacyclin sensitivity of human platelets after jogging and squash. Prostaglandins Med (1981) 0.81
Generation of the membrane attack complex during haemodialysis: impact of classical and alternative pathway components. Clin Sci (Lond) (1990) 0.81
Effect of experimentally induced diabetes on swine vascular prostacyclin (PGI2) synthesis. Artery (1980) 0.81
Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition. Br J Clin Pharmacol (1982) 0.81
The behaviour of various platelet function tests during long-term prostacyclin infusion in patients with peripheral vascular disease. Thromb Haemost (1983) 0.81
Hypothenar hammer syndrome. Eur Radiol (2000) 0.80
Rebound platelet activation during continuous epoprostenol infusion. Lancet (1984) 0.80
Human rectal mucosa generates prostacyclin. Lancet (1978) 0.80
Prostacyclin synthesis in human lymphatics. Lymphology (1980) 0.80
Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study). Transfusion (1996) 0.79
Platelet aggregation and reversible platelet aggregates in type I-diabetes staged by retinal fluorescein angiography. Atherosclerosis (1981) 0.79
Platelet adhesion and platelet thrombus formation on subendothelium of human arteries and veins exposed to flowing blood in vitro. A comparison with rabbit aorta. Haemostasis (1979) 0.79
Enhanced prostacyclin formation in veins of women under chronical treatment with oral contraceptive drugs. Pharmacol Res Commun (1980) 0.79
[Probiotics for the prevention of antibiotic-induced diarrhea]. Z Gastroenterol (2012) 0.79
Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathy. Horm Metab Res Suppl (1981) 0.79
Prostacyclin-like activity of endothelium and subendothelium - important for atherosclerosis? Experientia (1978) 0.78
20 mg aspirin daily--evidence for a clinical future of this extremely low-dose in arterial disease? Vasa (1988) 0.78
Rapid screening for bacteriuria in pregnancy. Infection (1992) 0.78
Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet alpha-granule release in chronic renal failure. Thromb Haemost (1988) 0.78
Enhanced prostacyclin synthesis in acute human kidney transplant rejection. Proc Eur Dial Transplant Assoc (1980) 0.78
[Arterial radiation injuries]. Vasa (1977) 0.78
Cortex and medulla of rat kidney generate different amounts of PG I2-like activity. Thromb Res (1978) 0.77
Enhanced 6-oxo-PGF1 alpha levels in plasma during hemodialysis. Prostaglandins Med (1980) 0.77
Elevated plasma beta-thromboglobulin levels in multiple myeloma and in polycythaemia vera. Acta Haematol (1979) 0.77
[Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4]. Acta Med Austriaca Suppl (1979) 0.77
Does prostacyclin (PGI2) regulate human arterial intima smooth muscle cell proliferation in early atherogenesis? Blood Vessels (1980) 0.77
[Prostacyclin as a protective factor for blood vessels]. Fortschr Med (1980) 0.77
Effect on nitroglycerin and other organic nitrates on the in-vitro biosynthesis of arachidonic acid-metabolites in washed human platelets. Prostaglandins Leukot Med (1984) 0.76
Serial recording of sensory evoked potentials: a noninvasive prognostic indicator in fulminant liver failure. Hepatology (1994) 0.76
Recombinant human erythropoietin: a multipotential hemopoietic growth factor in vivo and in vitro. Contrib Nephrol (1990) 0.76
Is the variation in the susceptibility of various species to atherosclerosis due to inborn differences in prostacyclin (PGI2) formation. Experientia (1980) 0.76
Sentinel lymph node detection with large human serum albumin colloid particles in breast cancer. Eur J Nucl Med Mol Imaging (2003) 0.76
Pulmonary and antiaggregatory effects of prostacyclin after inhalation and intravenous infusion. Respiration (1984) 0.76
Prostacyclin production by vascular smooth-muscle cells. Lancet (1978) 0.76
Development of optimal infusion regimens for epoprostenol using radio labelled platelet uptake over atherosclerotic lesions in man. Br J Clin Pharmacol (1987) 0.75
Erythropoietin response to folic acid substitution. Nephron (1999) 0.75
Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin. BMJ (1990) 0.75
Effect of angiotensin II infusion on a prostaglandin I2-metabolite and on left ventricular function. Basic Res Cardiol (1986) 0.75
Detection of aneurysms by gamma-camera imaging after injection of autologous labelled platelets. Lancet (1984) 0.75
Prostacyclin activity in rat kidney stimulated by angiotensin II. Br J Exp Pathol (1979) 0.75
[In vitro prostaglandin I2 synthesis in normal and pathologically-changed human leg veins]. Vasa (1986) 0.75
Effect of captopril on renin and blood pressure in cirrhosis. Eur J Clin Pharmacol (1987) 0.75
[Technic of radioactive labeling of autologous human thrombocytes using 111-indium-oxine and 111-indium-oxine-sulfate and their clinical use]. Wien Klin Wochenschr (1984) 0.75
[Hemofiltration in chronic heart failure]. Acta Med Austriaca (1985) 0.75
Aortic response to renovascular hypertension. Artery (1980) 0.75
[Influence of adjuvant hormonal therapy on the whole female organism: benefit versus potential injury]. Gynakol Geburtshilfliche Rundsch (1998) 0.75
[Hemodynamic effects of nitroglycerin following acute inhibition of prostaglandin synthesis]. Z Kardiol (1986) 0.75
Value of circulating immune parameters in renal transplantation. Transplant Proc (1997) 0.75
[Current status of the prostacyclin story for clinical use]. Vasa (1981) 0.75
Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure. Cardiology (1983) 0.75
Platelet microaggregates and release of endogenous prostacyclin during the initial phase of haemodialysis. Proc Eur Dial Transplant Assoc (1981) 0.75
Inhibition of acetylcholine-induced bronchoconstriction in asthmatics by nifedipine. Respiration (1986) 0.75
[Takayasu arteritis--Kimoto type II. Case report]. Vasa (1985) 0.75
[Vibration syndrome--a case report of a metal grinder]. Vasa (1986) 0.75
[Methods for scanning electron microscopic study of thrombocytes]. Vasa (1980) 0.75
[Dose-dependent increase in prostacyclin synthesis from various vascular tissues by dipyridamole]. Wien Klin Wochenschr (1982) 0.75
Plasma vasopressin as influenced by acute and chronic blockade of the renin-angiotensin system. J Hypertens Suppl (1985) 0.75
[Sipple syndrome (bilateral phaeochromocytoma medullary C-cell carcinoma of the thyroid gland) with exceptionally prolonged clinical course]. Wien Klin Wochenschr (1982) 0.75
Bicyclo-prostaglandin E2 metabolite in congestive heart failure and relation to vasoconstrictor neurohumoral principles. Am J Cardiol (1986) 0.75
Calcitonin temporarily increases 6-oxo-prostaglandin F1 alpha-levels in man. Prostaglandins (1980) 0.75
Standardized ergometer exercise in trained rowers: effect on reversible platelet microaggregates and platelet aggregation. Vasa (1981) 0.75
[Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension]. Acta Med Austriaca (1984) 0.75
[Molsidomine, a coronary drug with platelet-aggregating inhibitory activity]. Z Kardiol (1982) 0.75
Cardial decompensation caused by hypertension and polyglobulia associated with multiple renal oncocytomas. Clin Nephrol (1985) 0.75
[Value of the detection of arteriosclerotic lesions with labeled autologous thrombocytes]. Acta Med Austriaca (1982) 0.75
Right ventricular performance in chronic air flow obstruction. Respiration (1984) 0.75
[Age dependence of vascular prostacyclin formation in man (author's transl)]. Aktuelle Gerontol (1980) 0.75
Activation of platelet in vivo function and plasma levels of catecholamines and growth hormone during bicycle exercise in juvenile diabetes and healthy individuals. Curr Probl Clin Biochem (1982) 0.75
Acute and chronic effects of captopril on bicyclo-PGEm, the stable bicyclic end product of prostaglandin E2 in essential hypertension. Nephron (1986) 0.75
Influence of proteoglycans (PG) and glycosaminoglycans (GAG) on ADP-, collagen- and thrombin-induced platelet aggregation. Artery (1980) 0.75
[Acute inhibition of angiotensin-converting enzyme by captopril. Hemodynamic and biochemical aspects in normotension and essential hypertension]. Acta Med Austriaca (1982) 0.75
Left ventricular function in well-controlled insulin-dependent (type I) diabetics--an echophonocardiographic study. Cardiology (1986) 0.75
[Hemofiltration and the neurohumoral system in patients with severe heart failure]. Acta Med Austriaca (1985) 0.75